BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29331492)

  • 1. Prognostic Value of the Expression of DNA Repair-Related Biomarkers Mediated by Alcohol in Gastric Cancer Patients.
    Zhang Y; Wu H; Yang F; Ning J; Li M; Zhao C; Zhong S; Gu K; Wang H
    Am J Pathol; 2018 Feb; 188(2):367-377. PubMed ID: 29331492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
    Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
    World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic effects of abnormal DNA damage response protein expression in breast cancer.
    Suh KJ; Ryu HS; Lee KH; Kim H; Min A; Kim TY; Yang Y; Lee HB; Moon HG; Han SW; Oh DY; Han W; Park IA; Noh DY; Im SA
    Breast Cancer Res Treat; 2019 May; 175(1):117-127. PubMed ID: 30671767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of BRCA1 expression in gastric cancer.
    Chen W; Wang J; Li X; Li J; Zhou L; Qiu T; Zhang M; Liu P
    Med Oncol; 2013 Mar; 30(1):423. PubMed ID: 23292835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of Runx2 mediating alcohol-induced Brf1 expression and RNA Pol III gene transcription.
    Hong Z; Fang Z; Lei J; Shi G; Zhang Y; He Z; Li B W; Zhong S
    Chem Biol Interact; 2020 May; 323():109057. PubMed ID: 32198086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.
    Thike AA; Tan PH; Ikeda M; Iqbal J
    Histopathology; 2016 Apr; 68(5):702-12. PubMed ID: 26259780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of the Immunohistochemical Expression of RAD51 and BRCA2 in Gastric Adenocarcinoma.
    Pádua JDB; Mariano CFA; Fabro AT; Tirapelli DPDC; Sankarankutty AK; Dos Santos JS; Brunaldi MO
    J Histochem Cytochem; 2022 Mar; 70(3):199-210. PubMed ID: 34978208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
    Cheng Y; Yang B; Xi Y; Chen X
    Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA expression of BRCA1, PIAS1, and PIAS4 and survival after second-line docetaxel in advanced gastric cancer.
    Wei J; Costa C; Ding Y; Zou Z; Yu L; Sanchez JJ; Qian X; Chen H; Gimenez-Capitan A; Meng F; Moran T; Benlloch S; Taron M; Rosell R; Liu B
    J Natl Cancer Inst; 2011 Oct; 103(20):1552-6. PubMed ID: 21862729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 and BRCA2 expression patterns and prognostic significance in digestive system cancers.
    Wang GH; Zhao CM; Huang Y; Wang W; Zhang S; Wang X
    Hum Pathol; 2018 Jan; 71():135-144. PubMed ID: 29126833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of DNA Damage Response Markers in Early-Onset or Familial Gastric Cancers.
    Kim HS; Kim JW; Hwang IG; Lee HS; Kim WH
    Asian Pac J Cancer Prev; 2019 May; 20(5):1369-1376. PubMed ID: 31127894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Krüppel-Like Factor 7 is a Marker of Aggressive Gastric Cancer and Poor Prognosis.
    Jiang Z; Yu T; Fan Z; Yang H; Lin X
    Cell Physiol Biochem; 2017; 43(3):1090-1099. PubMed ID: 28977783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of PTPRD correlates with poor prognosis in gastric adenocarcinoma.
    Wang D; Wang L; Zhou J; Pan J; Qian W; Fu J; Zhang G; Zhu Y; Liu C; Wang C; Jin Z; He Z; Wu J; Shi B
    PLoS One; 2014; 9(11):e113754. PubMed ID: 25412184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
    Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
    World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma.
    Yan S; He F; Luo R; Wu H; Huang M; Huang C; Li Y; Zhou Z
    Tumour Biol; 2016 May; 37(5):6125-33. PubMed ID: 26611647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic role of MAC30 in advanced gastric cancer patients receiving platinum-based chemotherapy.
    Wu X; Zhou F; Ji X; Ren K; Shan Y; Mao X; Fen Y; Chen R; Ding H; Fu X
    Future Oncol; 2017 Dec; 13(29):2691-2696. PubMed ID: 28972404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer.
    Grabsch H; Dattani M; Barker L; Maughan N; Maude K; Hansen O; Gabbert HE; Quirke P; Mueller W
    Clin Cancer Res; 2006 Mar; 12(5):1494-500. PubMed ID: 16533773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
    Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy.
    Nakamura J; Kitajima Y; Kai K; Hashiguchi K; Hiraki M; Noshiro H; Miyazaki K
    Int J Cancer; 2010 Sep; 127(5):1158-71. PubMed ID: 20020496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.